Abstract
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
Jan Bondeson, Sarah Lauder, Shane Wainwright, Nick Amos, Amy Evans, Clare Hughes, Marc Feldmann and Bruce Caterson
The Journal of Rheumatology March 2007, 34 (3) 523-533;
Jan Bondeson
Sarah Lauder
Shane Wainwright
Nick Amos
Amy Evans
Clare Hughes
Marc Feldmann
In this issue
The Journal of Rheumatology
Vol. 34, Issue 3
1 Mar 2007
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
Jan Bondeson, Sarah Lauder, Shane Wainwright, Nick Amos, Amy Evans, Clare Hughes, Marc Feldmann, Bruce Caterson
The Journal of Rheumatology Mar 2007, 34 (3) 523-533;
Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent.
Jan Bondeson, Sarah Lauder, Shane Wainwright, Nick Amos, Amy Evans, Clare Hughes, Marc Feldmann, Bruce Caterson
The Journal of Rheumatology Mar 2007, 34 (3) 523-533;